The TMEM131L gene, known for encoding a transmembrane protein, is speculated to potentially interact with the chemotherapy drug capecitabine, possibly influencing its pharmacodynamics by affecting drug uptake or interaction with cellular targets, though this mechanism remains unclear due to the lack of detailed studies.